CLINICAL AND LABORATORY COMPARISON OF BOTULISM FROM TOXIN TYPE-A, TYPE-B, AND TYPE-E IN THE UNITED-STATES, 1975-1988

被引:131
作者
WOODRUFF, BA
GRIFFIN, PM
MCCROSKEY, LM
SMART, JF
WAINWRIGHT, RB
BRYANT, RG
HUTWAGNER, LC
HATHEWAY, CL
机构
[1] CTR DIS CONTROL,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ENTER DIS BRANCH,ATLANTA,GA 30333
[2] CTR DIS CONTROL,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA 30333
[3] CTR DIS CONTROL,NATL CTR INFECT DIS,ARCTIC INVEST PROGRAM,ATLANTA,GA 30333
[4] CALIF DEPT HLTH SERV,MICROBIAL DIS LAB,MICROBIOL CONSUMER PROD UNIT,BERKELEY,CA
关键词
D O I
10.1093/infdis/166.6.1281
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cases of adult botulism (n = 309) were studied to identify clinical differences between toxin types and to evaluate the sensitivity of diagnostic laboratory testing. Patients with illness from type E toxin had the shortest incubation periods. Sporadic case-patients were more severely ill: 85% required intubation compared with only 42% in multiperson outbreaks. Of patients with type A botulism, 67% required intubation compared with 52% with type B and 39% with type E. Toxin testing was positive for 40%-44% of serum and stool specimens obtained within 3 days of toxin ingestion and for 15%-23% of specimens obtained thereafter, while 37% of stool specimens obtained >3 days after toxin ingestion were positive by culture. Patients with type A botulism have more severe illness. In general, specimens obtained early are more likely to be positive by toxin assay, and stool cultures are more sensitive than toxin detection for specimens obtained later in the illness.
引用
收藏
页码:1281 / 1286
页数:6
相关论文
共 18 条
[1]  
CHERINGTON M, 1982, MUSCLE NERVE, V5, pS28
[2]  
DEAN AD, 1990, EPI INFOR VERSION 5
[3]  
DOLMAN C. E., 1957, CANADIAN JOUR PUBL HEALTH, V48, P187
[4]   COPROEXAMINATION FOR BOTULINAL TOXIN AND CLOSTRIDIUM-BOTULINUM - NEW PROCEDURE FOR LABORATORY DIAGNOSIS OF BOTULISM [J].
DOWELL, VR ;
MCCROSKEY, LM ;
HATHEWAY, CL ;
LOMBARD, GL ;
HUGHES, JM ;
MERSON, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (17) :1829-1832
[5]  
HABERMANN E, 1986, CURR TOP MICROBIOL, V129, P93
[6]  
Hatheway C.L., 1988, LAB DIAGNOSIS INFECT, P111
[7]   CLINICAL-FEATURES OF TYPE-A AND TYPE-B FOODBORNE BOTULISM [J].
HUGHES, JM ;
BLUMENTHAL, JR ;
MERSON, MH ;
LOMBARD, GL ;
DOWELL, VR ;
GANGAROSA, EJ .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) :442-445
[8]   TYPE-A BOTULISM FROM SAUTEED ONIONS - CLINICAL AND EPIDEMIOLOGIC OBSERVATIONS [J].
MACDONALD, KL ;
SPENGLER, RF ;
HATHEWAY, CL ;
HARGRETT, NT ;
COHEN, ML .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (09) :1275-1278
[9]  
Sakagichi G, 1983, PHARMACOL THERAPEUT, V19, P165
[10]   RESTAURANT-ASSOCIATED TYPE-A BOTULISM - TRANSMISSION BY POTATO SALAD [J].
SEALS, JE ;
SNYDER, JD ;
EDELL, TA ;
HATHEWAY, CL ;
JOHNSON, CJ ;
SWANSON, RC ;
HUGHES, JM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 113 (04) :436-444